Abstract:Background Andrographolide (Andro), a diterpenoid lactone, has been used for treatment of various cancers with less adverse effects. However, the underlying mechanisms regarding its anti-tumor mechanism still remain unclear. Methods Cell viability and proliferation were measured by CCK8 and CFSE dilution assay. The localization of p50/p65 or cytochrome c was determined using confocal immunofluorescence. Streptavidin-agarose pulldown or ChIP assays were used to detect the binding of multiple transactivators to COX-2 promoter. The promoter activity was examined by a dual-Luciferase reporter assay. The functions of Andro on COX-2-mediated angiogenesis were also investigated using human HUVEC cells through tube formation and spheroids sprouting assay. The in vivo anti-tumor efficacy of Andro was analyzed in xenografts nude mice. Results The results indicated that Andro could significantly inhibit the proliferation of human breast cancers, and suppress COX-2 expression at both protein and mRNA levels. Furthermore, Andro could dose-dependently inhibit COX-2-mediated angiogenesis in human endothelial cells. We have also found that Andro significantly promoted the activation of cytochrome c and activated caspase-dependent apoptotic signaling pathway. Our further explorations demonstrated that Andro inhibited the binding of the transactivators CREB2, C-Fos and NF-κB and blocked the recruitment of coactivator p300 to COX-2 promoter. Moreover, Andro could effectively inhibit the activity of p300 histone acetyltransferase (HAT), thereby attenuating the p300-mediated acetylation of NF-κB. Besides, Andro could also dramatically inhibit the migration, invasion and tubulogenesis of HUVECs in vitro . In addition, Andro also exhibited effective anti-tumor efficacy as well as angiogenesis inhibition in vivo . Conclusion In current study, we explore the potential effects of Andro in suppressing breast cancer growth and tumor angiogenesis, as well as the precise mechanisms. This work demonstrated the potential anti-cancer effects of Andro, indicating that Andro could inhibit COX-2 expression through attenuating p300 HAT activity and suppress angiogenesis via VEGF pathway, and thereby could be developed as an antitumor agent for the treatment of breast cancer.

The therapeutic potential of andrographolide in cancer treatment

Advances in Ameliorating Inflammatory Diseases and Cancers by Andrographolide: Pharmacokinetics, Pharmacodynamics, and Perspective

Andrographolide and its derivatives: Current achievements and future perspectives

Current Evidence on Molecular Mechanisms of Andrographolide in Cancer

Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer

Targeting signaling pathways with andrographolide in cancer therapy (Review)

Chrysophanol: A Promising Natural Compound in Cancer Therapy - Mechanistic Insights and Future Perspectives

The Prowess of Andrographolide As a Natural Weapon in the War Against Cancer

Andrographolide Inhibits Breast Cancer Through Suppressing COX-2 Expression and Angiogenesis Via Inactivation of P300 Signaling and VEGF Pathway.

Current Trends on Repurposing and Pharmacological Enhancement of Andrographolide

Biological properties of andrographolide, an active ingredient of Andrographis Paniculata: a narrative review

Study on the mechanism of andrographolide activation

Clinical Efficacy and Potential Mechanisms of Acupoint Stimulation Combined With Chemotherapy in Combating Cancer: A Review and Prospects

Recent progress on triterpenoid derivatives and their anticancer potential

Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs

A Quantitative Chemical Proteomics Approach to Profile the Specific Cellular Targets of Andrographolide, a Promising Anticancer Agent That Suppresses Tumor Metastasis*

Cellular and molecular mechanisms of oroxylin A in cancer therapy: Recent advances

Advances in the roles of glycyrrhizic acid in cancer therapy

Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells.

Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response

Uncover the anticancer potential of lycorine